88 related articles for article (PubMed ID: 15882186)
1. Long-term progression-free survival of invasive uterine cervical carcinoma infected with human immunodeficiency virus: a case report.
Niibe Y; Karasawa K; Mizutani K
Int J Gynecol Cancer; 2005; 15(3):558-60. PubMed ID: 15882186
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
3. Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV.
Amit A; Edwards CL; Athey P; Kaplan AL
Int J Gynecol Cancer; 2001; 11(1):78-80. PubMed ID: 11285038
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus infection and invasive cervical carcinoma.
Maiman M; Fruchter RG; Guy L; Cuthill S; Levine P; Serur E
Cancer; 1993 Jan; 71(2):402-6. PubMed ID: 8093678
[TBL] [Abstract][Full Text] [Related]
5. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection.
Rellihan MA; Dooley DP; Burke TW; Berkland ME; Longfield RN
Gynecol Oncol; 1990 Mar; 36(3):435-8. PubMed ID: 2318457
[TBL] [Abstract][Full Text] [Related]
6. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
7. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
8. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in the primary invasive vaginal carcinoma].
Kojs Z; Urbański K; Fabisiak W; Reinfuss M
Ginekol Pol; 2002 Mar; 73(3):163-6. PubMed ID: 12092247
[TBL] [Abstract][Full Text] [Related]
10. HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
Simonds HM; Neugut AI; Jacobson JS
Int J Gynecol Cancer; 2015 Jun; 25(5):884-90. PubMed ID: 25853380
[TBL] [Abstract][Full Text] [Related]
11. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
12. Invasive cervical cancer and human immunodeficiency virus (HIV) infection in KwaZulu-Natal, South Africa.
Moodley M; Mould S
J Obstet Gynaecol; 2005 Oct; 25(7):706-10. PubMed ID: 16263548
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer in patients infected with the human immunodeficiency virus.
Leitao MM; White P; Cracchiolo B
Cancer; 2008 Jun; 112(12):2683-9. PubMed ID: 18438877
[TBL] [Abstract][Full Text] [Related]
14. Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 May; 170(5):269-76. PubMed ID: 8197549
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group.
Calkins A; Stehman FB; Bundy B; Benda JA; Mannel RS; Seago P; Cappuccini F; Alvarez RD; Monk BJ; Maiman M
Int J Gynecol Cancer; 2006; 16(2):660-3. PubMed ID: 16681743
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy results for patients undergoing inappropriate surgery in the presence of invasive cervical carcinoma.
Choi DH; Huh SJ; Nam KH
Gynecol Oncol; 1997 Jun; 65(3):506-11. PubMed ID: 9190983
[TBL] [Abstract][Full Text] [Related]
19. Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman.
Lee YC; Holcomb K; Buhl A; Holden J; Abulafia O
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):380-2. PubMed ID: 10985898
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
